Yasuo Urata

3.6k total citations
112 papers, 2.9k citations indexed

About

Yasuo Urata is a scholar working on Genetics, Biotechnology and Oncology. According to data from OpenAlex, Yasuo Urata has authored 112 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Genetics, 69 papers in Biotechnology and 37 papers in Oncology. Recurrent topics in Yasuo Urata's work include Virus-based gene therapy research (84 papers), Cancer Research and Treatments (69 papers) and RNA Interference and Gene Delivery (24 papers). Yasuo Urata is often cited by papers focused on Virus-based gene therapy research (84 papers), Cancer Research and Treatments (69 papers) and RNA Interference and Gene Delivery (24 papers). Yasuo Urata collaborates with scholars based in Japan, United States and China. Yasuo Urata's co-authors include Toshiyoshi Fujiwara, Shunsuke Kagawa, Noriaki Tanaka, Hiroyuki Kishimoto, Hiroshi Tazawa, Robert M. Hoffman, Shinji Kuroda, Yuuri Hashimoto, Futoshi Uno and Shuya Yano and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Yasuo Urata

108 papers receiving 2.8k citations

Peers

Yasuo Urata

GENET

ONCOL

BIOTE

Victor Krasnykh United States

Klaus Bosslet Germany

Masahiko Nishizaki Japan

Wolfgang Kemmner Germany

Sachiko Inubushi Japan

He Zhou China

Tiziana Triulzi Italy

Fuminori Teraishi Japan

Beth A. Pulaski United States

James Watters United States

Victor Krasnykh United States

Yasuo Urata

4.2k ×2.8

GENET

2.5k ×2.0

ONCOL

619 ×0.5

BIOTE

3.5k ×3.2

79 ×0.2

Citations per year, relative to Yasuo Urata Yasuo Urata (= 1×) peers Victor Krasnykh

Countries citing papers authored by Yasuo Urata

Since Specialization

Citations

This map shows the geographic impact of Yasuo Urata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasuo Urata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasuo Urata more than expected).

Fields of papers citing papers by Yasuo Urata

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasuo Urata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasuo Urata. The network helps show where Yasuo Urata may publish in the future.

Co-authorship network of co-authors of Yasuo Urata

This figure shows the co-authorship network connecting the top 25 collaborators of Yasuo Urata. A scholar is included among the top collaborators of Yasuo Urata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasuo Urata. Yasuo Urata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hashimoto, Masashi, Shinji Kuroda, Nobuhiko Kanaya, et al.. (2024). Long-term activation of anti-tumor immunity in pancreatic cancer by a p53-expressing telomerase-specific oncolytic adenovirus. British Journal of Cancer. 130(7). 1187–1195. 5 indexed citations

Hori, Naoto, Hiroshi Tazawa, Yuncheng Li, et al.. (2023). Intraperitoneal Administration of p53-armed Oncolytic Adenovirus Inhibits Peritoneal Metastasis of Diffuse-type Gastric Cancer Cells. Anticancer Research. 43(11). 4809–4821. 2 indexed citations

Tazawa, Hiroshi, Joe Hasei, Yasuaki Yamakawa, et al.. (2021). Oncolytic virotherapy reverses chemoresistance in osteosarcoma by suppressing MDR1 expression. Cancer Chemotherapy and Pharmacology. 88(3). 513–524. 13 indexed citations

Takehara, Kiyoto, Hiroshi Tazawa, Yuuri Hashimoto, et al.. (2015). Targeted Photodynamic Virotherapy Armed with a Genetically Encoded Photosensitizer. Molecular Cancer Therapeutics. 15(1). 199–208. 18 indexed citations

Shigeyasu, Kunitoshi, Hiroshi Tazawa, Yuuri Hashimoto, et al.. (2014). Fluorescence virus-guided capturing system of human colorectal circulating tumour cells for non-invasive companion diagnostics. Gut. 64(4). 627–635. 22 indexed citations

Hasei, Joe, Tsuyoshi Sasaki, Hiroshi Tazawa, et al.. (2013). Dual Programmed Cell Death Pathways Induced by p53 Transactivation Overcome Resistance to Oncolytic Adenovirus in Human Osteosarcoma Cells. Molecular Cancer Therapeutics. 12(3). 314–325. 53 indexed citations

Yano, Shuya, Hiroshi Tazawa, Yuuri Hashimoto, et al.. (2013). A Genetically Engineered Oncolytic Adenovirus Decoys and Lethally Traps Quiescent Cancer Stem–like Cells in S/G2/M Phases. Clinical Cancer Research. 19(23). 6495–6505. 64 indexed citations

Li, Guidong, Hiroyuki Kawashima, Akira Ogose, et al.. (2013). Telomelysin shows potent antitumor activity through apoptotic and non‐apoptotic cell death in soft tissue sarcoma cells. Cancer Science. 104(9). 1178–1188. 4 indexed citations

Miyamoto, Shohei, Hiroyuki Inoue, Takafumi Nakamura, et al.. (2012). Coxsackievirus B3 Is an Oncolytic Virus with Immunostimulatory Properties That Is Active against Lung Adenocarcinoma. Cancer Research. 72(10). 2609–2621. 188 indexed citations

10.

Sasaki, Tsuyoshi, Hiroshi Tazawa, Joe Hasei, et al.. (2012). Preclinical evaluation of telomerase-specific oncolytic virotherapy for human bone and soft tissue sarcomas. Okayama Igakkai Zasshi (Journal of Okayama Medical Association). 124(2). 105–110. 1 indexed citations

11.

Sasaki, Tsuyoshi, Hiroshi Tazawa, Joe Hasei, et al.. (2011). Preclinical Evaluation of Telomerase-Specific Oncolytic Virotherapy for Human Bone and Soft Tissue Sarcomas. Clinical Cancer Research. 17(7). 1828–1838. 43 indexed citations

12.

Kuroda, Shinji, Toshiya Fujiwara, Yasuhiro Shirakawa, et al.. (2010). Telomerase-Dependent Oncolytic Adenovirus Sensitizes Human Cancer Cells to Ionizing Radiation via Inhibition of DNA Repair Machinery. Cancer Research. 70(22). 9339–9348. 61 indexed citations

13.

Sakai, Ryo, Shunsuke Kagawa, Toru Kojima, et al.. (2010). Preclinical Evaluation of Differentially Targeting Dual Virotherapy for Human Solid Cancer. Molecular Cancer Therapeutics. 9(6). 1884–1893. 18 indexed citations

14.

Liu, Dong, Toru Kojima, Masaaki Ouchi, et al.. (2009). Preclinical evaluation of synergistic effect of telomerase-specific oncolytic virotherapy and gemcitabine for human lung cancer. Molecular Cancer Therapeutics. 8(4). 980–987. 40 indexed citations

15.

Kurihara, Yuji, Yuichi Watanabe, Toru Kojima, et al.. (2009). Telomerase-Specific Virotheranostics for Human Head and Neck Cancer. Clinical Cancer Research. 15(7). 2335–2343. 23 indexed citations

16.

Kishimoto, Hiroyuki, Ming Zhao, Katsuhiro Hayashi, et al.. (2009). In vivo internal tumor illumination by telomerase-dependent adenoviral GFP for precise surgical navigation. Proceedings of the National Academy of Sciences. 106(34). 14514–14517. 119 indexed citations

17.

Ikeda, Yoshihiro, Toru Kojima, Shinji Kuroda, et al.. (2009). A Novel Antiangiogenic Effect for Telomerase-Specific Virotherapy through Host Immune System. The Journal of Immunology. 182(3). 1763–1769. 16 indexed citations

18.

Hashimoto, Yuuri, Yuichi Watanabe, Futoshi Uno, et al.. (2008). Establishment of biological and pharmacokinetic assays of telomerase‐specific replication‐selective adenovirus. Cancer Science. 99(2). 385–390. 57 indexed citations

19.

Watanabe, Takanori, Masayoshi Hioki, Toshiya Fujiwara, et al.. (2005). Histone deacetylase inhibitor FR901228 enhances the antitumor effect of telomerase-specific replication-selective adenoviral agent OBP-301 in human lung cancer cells. Experimental Cell Research. 312(3). 256–265. 69 indexed citations

20.

Ohkubo, Katsutoshi, et al.. (1995). Supramolecules I. Molecular Design of Transitions-State Analogue-Imprinted Polymer Catalysts-Stereoselective Esterolysis of Amino Acid Esters.. KOBUNSHI RONBUNSHU. 52(10). 644–649. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact